{
  "address1": "2438 Miyanoura-cho",
  "city": "Kagoshima",
  "zip": "891-1394",
  "country": "Japan",
  "phone": "81 9 9294 2600",
  "fax": "81 9 9294 3619",
  "website": "https://www.snbl.co.jp",
  "industry": "Diagnostics & Research",
  "industryKey": "diagnostics-research",
  "industryDisp": "Diagnostics & Research",
  "sector": "Healthcare",
  "sectorKey": "healthcare",
  "sectorDisp": "Healthcare",
  "longBusinessSummary": "Shin Nippon Biomedical Laboratories, Ltd., a contract research organization, engages in the pharmaceutical development, transactional research, and medipolis businesses in Japan and internationally. It offers non-clinical testing and non-clinical regulatory consulting for the development of pharmaceuticals, medical devices, or regenerative medicine products, including safety and pharmacology testing, and pharmacokinetic studies. The company also engages in licensing activities for proprietary products which utilize unique intranasal formulation delivery technology, discovery of future seeds, and business promotion activities; and development of artificial seed production for Japanese eels. In addition, it operates hotels accommodations facilities under the Villa Amafuru Oka and HOTEL Freesia names; and develops and operates geothermal and hot spring thermal power plants. Shin Nippon Biomedical Laboratories, Ltd. was founded in 1957 and is headquartered in Kagoshima, Japan.",
  "fullTimeEmployees": 1532,
  "companyOfficers": [
    {
      "maxAge": 1,
      "name": "Dr. Ryoichi  Nagata F.F.P.M., M.D., Ph.D.",
      "age": 67,
      "title": "President, Chairman, CEO, Group CFO, Fisheries Business Officer & Chief Health Officer",
      "yearBorn": 1958,
      "fiscalYear": 2010,
      "totalPay": 144061000,
      "exercisedValue": 0,
      "unexercisedValue": 0
    },
    {
      "maxAge": 1,
      "name": "Fumihiko  Makino",
      "title": "Senior Executive Officer, Financial Controller and GM of Finance & Accounting",
      "fiscalYear": 2010,
      "exercisedValue": 0,
      "unexercisedValue": 0
    },
    {
      "maxAge": 1,
      "name": "Toshiyuki  Iwata",
      "title": "Managing Executive Officer, R/PR Division Manager & Sustainability Officer",
      "fiscalYear": 2010,
      "exercisedValue": 0,
      "unexercisedValue": 0
    },
    {
      "maxAge": 1,
      "name": "Shinji  Nitanda",
      "age": 57,
      "title": "Senior MD of Corporate Development & Corporate Tax Administration and Director",
      "yearBorn": 1968,
      "fiscalYear": 2010,
      "exercisedValue": 0,
      "unexercisedValue": 0
    },
    {
      "maxAge": 1,
      "name": "Kyomi  Nagatoshi",
      "age": 59,
      "title": "Senior Managing Executive Officer, Head of General Affairs & Human Resources and Director",
      "yearBorn": 1966,
      "fiscalYear": 2010,
      "exercisedValue": 0,
      "unexercisedValue": 0
    },
    {
      "maxAge": 1,
      "name": "Mr. Ken  Takanashi CPA, MBA.",
      "age": 61,
      "title": "Executive VP of Group Corporate Management & Global Business & Director",
      "yearBorn": 1964,
      "fiscalYear": 2010,
      "exercisedValue": 0,
      "unexercisedValue": 0
    },
    {
      "maxAge": 1,
      "name": "Satoshi  Matsumoto",
      "age": 57,
      "title": "Managing Executive Officer & GM of Fisheries Division",
      "yearBorn": 1968,
      "fiscalYear": 2010,
      "exercisedValue": 0,
      "unexercisedValue": 0
    },
    {
      "maxAge": 1,
      "name": "Dr. Hideshi  Tsusaki DVM Ph.D.",
      "age": 58,
      "title": "Senior MD, President of Non-Clinical & Global Business Development and Director",
      "yearBorn": 1967,
      "fiscalYear": 2010,
      "exercisedValue": 0,
      "unexercisedValue": 0
    },
    {
      "maxAge": 1,
      "name": "Terumasa  Hirai",
      "title": "Managing Executive Officer & President and Representative Director of SNBL Ina Research Center",
      "fiscalYear": 2010,
      "exercisedValue": 0,
      "unexercisedValue": 0
    },
    {
      "maxAge": 1,
      "name": "Dr. Shu-Ichi  Kanazashi M.D., Ph.D.",
      "age": 65,
      "title": "Managing Executive Officer, CMO and General Manager of TR Business Division",
      "yearBorn": 1960,
      "fiscalYear": 2010,
      "exercisedValue": 0,
      "unexercisedValue": 0
    }
  ],
  "auditRisk": 1,
  "boardRisk": 7,
  "compensationRisk": 9,
  "shareHolderRightsRisk": 10,
  "overallRisk": 9,
  "governanceEpochDate": 1769904000,
  "compensationAsOfEpochDate": 1293753600,
  "executiveTeam": [],
  "maxAge": 86400,
  "priceHint": 2,
  "previousClose": 1679.0,
  "open": 1688.0,
  "dayLow": 1659.0,
  "dayHigh": 1700.0,
  "regularMarketPreviousClose": 1679.0,
  "regularMarketOpen": 1688.0,
  "regularMarketDayLow": 1659.0,
  "regularMarketDayHigh": 1700.0,
  "dividendRate": 50.0,
  "dividendYield": 2.98,
  "exDividendDate": 1774828800,
  "payoutRatio": 0.4472,
  "fiveYearAvgDividendYield": 2.29,
  "beta": -0.448,
  "trailingPE": 14.988374,
  "forwardPE": 18.158178,
  "volume": 146300,
  "regularMarketVolume": 146300,
  "averageVolume": 286450,
  "averageVolume10days": 334380,
  "averageDailyVolume10Day": 334380,
  "bid": 1672.0,
  "ask": 1677.0,
  "bidSize": 0,
  "askSize": 0,
  "marketCap": 69774958592,
  "fiftyTwoWeekLow": 1142.0,
  "fiftyTwoWeekHigh": 2005.0,
  "allTimeHigh": 3225.0,
  "allTimeLow": 185.0,
  "priceToSalesTrailing12Months": 2.223952,
  "fiftyDayAverage": 1710.32,
  "twoHundredDayAverage": 1563.83,
  "trailingAnnualDividendRate": 50.0,
  "trailingAnnualDividendYield": 0.029779632,
  "currency": "JPY",
  "tradeable": false,
  "enterpriseValue": 96238936064,
  "profitMargins": 0.12718001,
  "floatShares": 4082418,
  "sharesOutstanding": 41631836,
  "heldPercentInsiders": 0.51765,
  "heldPercentInstitutions": 0.24084999,
  "impliedSharesOutstanding": 41631836,
  "bookValue": 1269.667,
  "priceToBook": 1.3200312,
  "lastFiscalYearEnd": 1743379200,
  "nextFiscalYearEnd": 1774915200,
  "mostRecentQuarter": 1767139200,
  "earningsQuarterlyGrowth": -0.355,
  "netIncomeToCommon": 3990121984,
  "trailingEps": 111.82,
  "forwardEps": 92.3,
  "lastSplitFactor": "2:1",
  "lastSplitDate": 1127779200,
  "enterpriseToRevenue": 3.067,
  "enterpriseToEbitda": 18.201,
  "52WeekChange": 0.03641975,
  "SandP52WeekChange": 0.11527538,
  "lastDividendValue": 30.0,
  "lastDividendDate": 1774828800,
  "quoteType": "EQUITY",
  "currentPrice": 1676.0,
  "targetHighPrice": 3400.0,
  "targetLowPrice": 1780.0,
  "targetMeanPrice": 2590.0,
  "targetMedianPrice": 2590.0,
  "recommendationMean": 1.5,
  "recommendationKey": "strong_buy",
  "numberOfAnalystOpinions": 2,
  "totalCash": 15407722496,
  "totalCashPerShare": 370.095,
  "ebitda": 5287598080,
  "totalDebt": 41523400704,
  "quickRatio": 0.582,
  "currentRatio": 1.081,
  "totalRevenue": 31374307328,
  "debtToEquity": 78.041,
  "revenuePerShare": 753.613,
  "returnOnAssets": 0.0125899995,
  "returnOnEquity": 0.07981,
  "grossProfits": 13826464768,
  "earningsGrowth": -0.355,
  "revenueGrowth": -0.339,
  "grossMargins": 0.44069,
  "ebitdaMargins": 0.16853,
  "operatingMargins": 0.15221,
  "financialCurrency": "JPY",
  "symbol": "2395.T",
  "language": "en-US",
  "region": "US",
  "typeDisp": "Equity",
  "quoteSourceName": "Delayed Quote",
  "triggerable": false,
  "customPriceAlertConfidence": "LOW",
  "regularMarketChange": -3.0,
  "regularMarketDayRange": "1659.0 - 1700.0",
  "fullExchangeName": "Tokyo",
  "averageDailyVolume3Month": 286450,
  "fiftyTwoWeekLowChange": 534.0,
  "fiftyTwoWeekLowChangePercent": 0.4676007,
  "fiftyTwoWeekRange": "1142.0 - 2005.0",
  "fiftyTwoWeekHighChange": -329.0,
  "fiftyTwoWeekHighChangePercent": -0.16408977,
  "fiftyTwoWeekChangePercent": 3.641975,
  "earningsTimestampStart": 1754274600,
  "earningsTimestampEnd": 1754620200,
  "isEarningsDateEstimate": true,
  "epsTrailingTwelveMonths": 111.82,
  "epsForward": 92.3,
  "fiftyDayAverageChange": -34.319946,
  "fiftyDayAverageChangePercent": -0.02006639,
  "twoHundredDayAverageChange": 112.170044,
  "twoHundredDayAverageChangePercent": 0.071727775,
  "sourceInterval": 15,
  "exchangeDataDelayedBy": 20,
  "averageAnalystRating": "1.5 - Strong Buy",
  "shortName": "SHIN NIPPON BIOMEDICAL LABORATO",
  "longName": "Shin Nippon Biomedical Laboratories, Ltd.",
  "marketState": "PREPRE",
  "hasPrePostMarketData": false,
  "firstTradeDateMilliseconds": 1078704000000,
  "corporateActions": [],
  "regularMarketTime": 1771309800,
  "exchange": "JPX",
  "messageBoardId": "finmb_5877815",
  "exchangeTimezoneName": "Asia/Tokyo",
  "exchangeTimezoneShortName": "JST",
  "gmtOffSetMilliseconds": 32400000,
  "market": "jp_market",
  "esgPopulated": false,
  "cryptoTradeable": false,
  "regularMarketChangePercent": -0.17867778,
  "regularMarketPrice": 1676.0,
  "trailingPegRatio": null
}